jhikh @SIDPharm.bskysocial

Meet Dr. Tara Gadde, MD, MPH, one of our incredible ID fellows! Tara brings her passion for global health and antimicrobial stewardship to the program, but when she’s not in the hospital, you’ll probably find her hiking Bay Area trails or scouting out new restaurants. #FellowSpotlight

📣 ICYMI We have big news! @mad-id.bsky.social and SIDP are teaming up for an annual meeting! This meeting will bring innovation and science (and BCIDP credit!) in ID pharmacotherapy, be accessible for all, and create a welcoming space to form life-long connections. Save the date: May 14-17, 2026.

LAST CHANCE BEFORE JULY 1st DEADLINE! 📣 Registration is now open for the 5️⃣th Annual Alabama Infectious Diseases Society (@ALInfectDis) Antimicrobial Stewardship 💊 Conference! ✨ 🔗 Register here: aub.ethosce.com/content/alab...

📣 Registration is now open for the 5️⃣th Annual Alabama Infectious Diseases Society (ALIDS) Antimicrobial Stewardship 💊 Conference! ✨ 🔗 Register here: aub.ethosce.com/content/alab...

📣 Attention Program Directors! Sign up is OPEN! 🌟 MAD-ID is excited to spotlight your PGY2 ID pharmacy residency or ID pharmacy fellowship program in the upcoming academic year! 🎓 See eligibility criteria! Sign up: forms.office.com/r/86HfX98XqT @SIDPharm.bsky.social @accpinfdprn.bsky.social

🎥 At #MADID2025, Dr. Jose Alexander from @adventhealth.bsky.social in Orlando, discussed data that ceftolozane/tazobactam showed 98% susceptibility against ESBL E. coli but only 76% for K. pneumoniae. @mad-id.bsky.social #IDsky #MEDsky Full interview: www.contagionlive.com/view/ceftolo...

At #MADID2025, Dr. Alyssa Cox, PharmD, presented data showing fidaxomicin reduced 90-day C difficile recurrence rates to 7.9% vs. 19% with vancomycin, a 68.3% lower risk in high-risk hospitalized patients. @mad-id.bsky.social #IDsky #MEDsky Listen here: www.contagionlive.com/view/fidaxom...

At #MADID2025, Dr's. Julia F. & Christina Lee from UNC Medical Center presented that immunocompromised patients on OPAT had a 27.1% 30-day readmission rate compared to 14.1% in non-immunocompromised patients. @mad-id.bsky.social #IDsky #MEDsky Listen here: www.contagionlive.com/view/immunoc...

🎥 At #MADID2025, Dr. William Mikesell from IU Health shared findings showing no significant difference in treatment failure between doxycycline (20%) and minocycline (16%) for bone & joint infections. @mad-id.bsky.social #IDsky #MEDsky Listen here: www.contagionlive.com/view/no-sign...

🎥 At #MADID2025, Dr. Marc Scheetz, from Midwestern University, shares how PK/PD modeling and AUC-based dosing are helping clinicians make safer, more personalized antibiotic decisions—right at the bedside. @mad-id.bsky.social #IDsky #MEDsky #AMRsky Listen here: www.contagionlive.com/view/precisi...

Another great talk from #MADID2025 : Advances in Diagnostic and Laboratory Science with @romneyintn.bsky.social #microbiology @mad-id.bsky.social

#MADID2025 has wrapped up in Orlando, but we’re continuing our coverage. Look out for new interviews, research highlights, & expert insights all week! @mad-id.bsky.social #IDsky #MEDsky 🎥 Stay tuned for Dr. Tiffany Lee's interview this week! Coverage: www.contagionlive.com/conference/m...

Gram-positive bloodstream Infections #MADID2025 @erinmccreary.bsky.social @mad-id.bsky.social

At #MADID2025, Dr. Logan Brock presented that routine fungal blood cultures during sepsis evaluations may offer limited diagnostic value; a more targeted approach may be appropriate. #IDsky #MEDsky @mad-id.bsky.social Listen here: www.contagionlive.com/view/rethink...

Wrapping up our final day at #MADID2025 in Orlando! 🦠 💊 @mad-id.bsky.social #IDsky #MEDsky It was great to learn from & discuss the posters and presentations showcasing important work in infectious diseases & stewardship. Until next year! Conference coverage: www.contagionlive.com/conference/m...

🎥 At #MADID2025, Dr. Jiye Park from Massachusetts General Hospital shared data showing no added benefit from extending oral vancomycin after systemic antibiotics for CDI prophylaxis. @mad-id.bsky.social #IDsky #MEDsky Listen to more of the results here: www.contagionlive.com/view/oral-va...

Last day, best day! 🌞 🦠 Check out today's @mad-id.bsky.social‬ line up and have a safe journey home after the conference. 0800: Importance of Prevention and the Patient Experience 1000: What You May Have Missed in ID This Year! 1130: Meet the Professors

Finishing our final day of #MADID2025 with the acclaimed "What did you miss in ID" Drs. Zahra Kassamali Escobar and Jamie Wagner will catch us up on critical publications from 2024-2025! 🤓 @sidpharm.bsky.social @accpinfdprn.bsky.social @contagionlive.bsky.social

Starting our 🔥 final day of #MADID2025 with Armando Nahum and Dr. Marin Schweizer speaking on the importance of the ♥️ patient experience and 😷 infection prevention. @sidpharm.bsky.social @accpinfdprn.bsky.social @contagionlive.bsky.social

Closing out Day 3️⃣ of #MADID2025, Drs. Zahra Kassamali-Escobar and Erin McCreary discuss the Gray in "Gray-M" Positive 🟣 Infections: ⏬ Step Down Therapy - Focus on 💊 Oral and Long Acting 💉 IV Antibiotics! @sidpharm.bsky.social @accpinfdprn.bsky.social @contagionlive.bsky.social

💡Great afternoon of interviews with insightful takeaways on improving patient care and implementing guidelines! 🦠💊 #MADID2025 @mad-id.bsky.social #IDsky #MEDsky #AMRsky Stay updated with onsite coverage here: www.contagionlive.com/conference/m...

More of #MADID2025 My favorite talk so far. New developments in antibacterial drugs : sulopenen, aztreonam-avibactam, and more. @ashlan-kunz-coyne.bsky.social @mad-id.bsky.social

At #MADID2025, Dakota Rorie, PharmD from Medical University of South Carolina, found fidaxomicin use for C. difficile stayed nearly flat post-guideline update, 48% to 49% for initial episodes. @mad-id.bsky.social #IDsky #MEDsky Listen to our interview here: www.contagionlive.com/view/fidaxom...

Next up at #MADID2025, Drs. Cesar Arias and Jason Pogue discuss 🦠 Challenging Gram ➕ and Gram ➖ Organisms @sidpharm.bsky.social @accpinfdprn.bsky.social @contagionlive.bsky.social

Conferences are 💸 EXPENSIVE! MAD-ID is PROUD to provide ✨ $20,000 ✨ in grants to support trainees attending and presenting at the #MADID2025 meeting. @sidpharm.bsky.social @accpinfdprn.bsky.social @contagionlive.bsky.social

Started today at #MADID2025 w/ Dr. Marc Scheetz breaking down PK/PD clinical applications & outcomes. 🧪 Followed by Dr. Jose Alexander highlighting data on ceftolozane/tazobactam activity against ESBL-producing organisms. 🦠 @mad-id.bsky.social #IDsky #MEDsky www.contagionlive.com/conference/m...

At #MADID2025, Dr. Rachel Kenney, from Henry Ford Hospital, highlighted evolving C diff management, from fidaxomicin as first-line therapy to new FDA-approved microbiome therapies like Vowst & Rebyota. @mad-id.bsky.social #IDsky #MEDsky #AMRsky 💊 Listen here: www.contagionlive.com/view/advanci...

Next up at #MADID2025, Drs. Pranita Tamma and Ashlan Kunz-Coyne discuss 🆕 New Developments in Antibiotics: Preparing for the 💊 Pipeline and Making the ✨ Most of New Antibiotics @sidpharm.bsky.social @accpinfdprn.bsky.social @contagionlive.bsky.social

Kicking off Day 3️⃣ of #MADID2025, Drs. Jason Pogue and Marc Scheetz discuss 🔥 Clinical Breakpoints and 📉 PK/PD Applications and Outcomes! @sidpharm.bsky.social @accpinfdprn.bsky.social @contagionlive.bsky.social

🎥 Happy Friday from #MADID2025! ☀️ We’re back at it with more on-site interviews today, featuring expert insights from presenters and speakers you won’t want to miss. @mad-id.bsky.social #IDsky #MEDsky Stay updated with coverage: www.contagionlive.com/conference/m...

Congratulations to our #MADID2025 Trainee Abstract Award Winners! @sidpharm.bsky.social @accpinfdprn.bsky.social @contagionlive.bsky.social

Here for the excellent content…aaaaand the waterslide 🙂‍↕️

At #MADID2025, Dr. Timmy Do from AdventHealth shared 2 refractory mpox cases in PLWH, both with CD4 <70 and VL >1,000. Do emphasized early CDC consultation, rapid drug access, & tailored escalation protocols. @mad-id.bsky.social #IDsky #MEDsky Listen here: www.contagionlive.com/view/managem...

Let's do this Day 3 @mad-id.bsky.social‬ 🌞🦠. Check out today's abbreviated line up: 0800: Contemporary PKPD 1000: New Developments in Antibiotics 1145: Satellite Symposium (⬇️ Line Infections in HD) 1330: Updates & Insights in Resistance 1530: Assessing the Gray in GP Infx 1700: Exhibitor reception

#MADID2025 Digital health and infectious diseases. Great talk! @mad-id.bsky.social

One of our favorite #MADID2025 sessions: 👨‍🏫 Posters and 🥂 Cocktail Reception! 📣 Starting Now in the Exhibit Hall! @sidpharm.bsky.social @accpinfdprn.bsky.social @contagionlive.bsky.social

At #MADID2025, Cadhan McFadden presented findings from a multidisciplinary clinic initiative using PEN-FAST scoring and oral amoxicillin challenges to improve penicillin allergy accuracy. #IDsky #MEDsky #AMRsky @mad-id.bsky.social Learn more: www.contagionlive.com/view/multidi...

Closing out day 2️⃣ of #MADID2025, Drs. Jerod Nagel and Robert Sawyer discuss 💊 Stewardship in 😖 Challenging Populations: 😷 Immunocompromised and 🚑 Surgical/Critically Ill @sidpharm.bsky.social @accpinfdprn.bsky.social @contagionlive.bsky.social

🎥 An energizing lunch hour at #MADID2025! More interviews, more perspectives, and more insights into infectious diseases, antimicrobial stewardship, and clinical practice. @mad-id.bsky.social #IDsky #MEDsky #AMRsky www.contagionlive.com/conference/m...

Next up at #MADID2025 Drs. Romney Humphries and Ashlan Kunz-Coyne discussing 🚀 Innovations in 🔬 Laboratory Science and 💊 Stewardship! @sidpharm.bsky.social @accpinfdprn.bsky.social @contagionlive.bsky.social

At the @mad-id.bsky.social #MADID2025 the yoga mats match the color scheme and upon closer examination even look like GPC-clusters 😂

#MADID2025: Dr. Elizabeth Dodds Ashley from Duke University discussed how clinicians can apply NHSN’s Antibiotic Resistance Option data to guide antibiotic use & improve monitoring in hospitals. @mad-id.bsky.social #IDsky #MEDsky #AMRsky Listen here: www.contagionlive.com/view/the-cha...

📣 Starting #MADID2025 plenary programming with ✨ keynote address ✨ from Dr. Timothy Aungst on 👩‍💻 Digital Health and Infectious Diseases! @sidpharm.bsky.social @accpinfdprn.bsky.social @contagionlive.bsky.social

At #MADID2025, Dr. Timothy Aungst, PharmD. Aungst, PharmD, Professor of Pharmacy Practice at the MCPH explores AI’s role in clinical education, decision-making, & stewardship. @mad-id.bsky.social #IDsky #MEDsky #AMRsky Listen to our full interview here: www.contagionlive.com/view/integra...

🎥 More insightful interviews this morning at #MADID2025! @mad-id.bsky.social Stay tuned: www.contagionlive.com/conference/m... Left: PGY-2 Pharmacy Resident, Cadhan McFadden Right: Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS

#MADID2025 Day 2: Great workshop with @erinmccreary.bsky.social about collaboration between the Micro lab and Antimicrobial Stewardship Teams. Another podcaster in the house. @mad-id.bsky.social @sidpharm.bsky.social

Started our morning at #MADID2025 with Dr. Timothy Aungst, PharmD discussing the role of AI in antimicrobial stewardship and infection prevention. #IDsky #MEDsky #AMRsky @mad-id.bsky.social Stay tuned for our interview: www.contagionlive.com/conference/m...

Day 2️⃣ of #MADID2025 begins with our second round of 👩‍🏫 workshops! 💩 Reducing C diff, 🔬 Micro lab collabs, 📅 Prioritizing your ASP day, and 🦠 Antibiotic resistance outcomes! @sidpharm.bsky.social @accpinfdprn.bsky.social @contagionlive.bsky.social

#MADID2025 Day one: Great workshop on using artificial intelligence in stewardship education. @mad-id.bsky.social